Ligand Pharma (LGND) Tops Q4 EPS by 43c, Offers Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to Ligand Pharma (LGND) Tops Q4 EPS by 43c, Offers Guidance

Ligand Reports Fourth Quarter and Full Year 2021 Financial Results

February 17, 2022 4:01 PM EST

Conference Call Begins at 4:30 p.m. Eastern Time Today

EMERYVILLE, Calif.--(BUSINESS WIRE)-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three and 12 months ended December 31, 2021, and provided an operating forecast and business updates. Ligand management will host a conference call today beginning at 4:30 p.m. Eastern time to discuss this announcement and answer questions.

2021 was an outstanding year for Ligand, both operationally and financially. The execution by the team and the performance of the business throughout the past several months... More